August 17, 2020
GENAC for the six months ended June 30, 2020, reported Gross premium written of $6.21 billion, 5% lower than the $6.56 billion reported for 2020. Reinsurance ceded fell 11% to close at $4.84 billion relative to $5.45 billion booked in 2019. Excess of loss reinsurance trended upwards by 16% to $78.64 million (2019: $67.73 million).
As a result, net premium written increased by 24% from $1.05 billion last year to $1.30 billion. Net premium written improved 21% within the second quarter to $609.57 million (2019: $505.75 million).
Net changes in earned premiums totalled $56.35 million, relative to changes in unearned premiums of $60.16 million recorded last year. Consequently, net premiums earned for the six months period grew by 37% to a total of $1.36 billion compared to $988.67 million for the prior year. While net premiums earned for the quarter increased by 36% to a total of $684.74 million (2019: $503.31 million).
Commission income fell by 8%, year over year, from $406.04 million in 2019 to $373.22 million in 2020, while commission expenses decreased by 3% from $259.65 million in 2019 to $250.82 million for the six months period.
Claims expenses saw an increase of 40%, closing the six months period at $887.30 million (2019: $632.83 million), while management expenses climbed by 36% to total $570.55 million compared to 2019’s total of $419.14 million.
Underwriting profit for the six months totalled of $21.22 million, this compares to an underwriting profit of $80.97 million booked in 2019. While for the quarter, underwriting loss totaled $21.61 million in comparison to a profit of $39.16 million in 2019.
Investment income closed at $89.68 million, a 13% improvement when compared with last year’s corresponding total of $79.07 million, while other income totalled $81.03 million for the period, relative to an income of $38.25 million in 2019. Other operating expenses grew by 44% to $46.81 million relative to $32.51 million in 2019.
Profit before taxation amounted to $142.41 million (2019: $163.56 million). Following taxes of $29.92 million (2019: $28.28 million). Net profit totalled $112.49 million for the period, a decrease of 17% compared to the $135.28 million reported last year. While net profit for the quarter totaled $37.77 million, compared to the $104.41 million reported last year. Net profit attributable to shareholders amounted to $129.91 million (2019: $135.28 million). While net profit attributable to shareholders for the quarter closed at $53.86 million (2019: $104.41 million).
Total comprehensive income year to date amounted to $45.47 million (2019: $131.29 million) for the period ended June 30, 2020. While total comprehensive loss for the quarter booked $22.88 million versus an income of $133.67 million in 2019.
As such, earning per share (EPS) for the period amounted to $0.13 (2019: $0.13) while EPS for the quarter amounted to $0.05 (2019: $0.10). The trailing twelve months EPS amounted to $0.61. The number of shares used in our calculations amounted to 1,031,250,000 units. The stock traded at $6.53 as at August 17, 2020.
Balance Sheet at a glance:-
Total Assets increased by 40% to $11 billion as at June 30, 2020 from $7.86 billion a year earlier. ‘Investment Securities’ contributed to the growth in assets with a 49% increase to $4.04 billion relative to $3.10 billion in 2019. ‘Investment properties’ also contributed to the increase with a 159% growth year over year to close at $543.33 million (2019: $209.68 million).
Shareholder’s Equity as at June 30, 2020 stood at $2.63 billion (2019: $2.19 billion) resulting in book value per share of $2.55 (2019: $2.12).
Analyst Certification -This research report is for information purposes only and should not be construed as a recommendation. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
